Randomized phase II trial comparing docetaxel with or without low-dose metronomic oral cyclophosphamide in first-line treatment of non-triple-negative advanced breast cancer.
Leiping Wang
No relevant relationships to disclose
Jian Zhang
No relevant relationships to disclose
Zhong Hua Wang
No relevant relationships to disclose
Biyun Wang
No relevant relationships to disclose
Jun Cao
No relevant relationships to disclose
Fangfang Lv
No relevant relationships to disclose
Sheng Zhang
No relevant relationships to disclose
Shao Zhimin
No relevant relationships to disclose
Xi-Chun Hu
No relevant relationships to disclose